BloombergLean L·
Roche Uses Recursion AI to Uncover New Brain Disease Targets
A new generation of AI companies believes it can reduce the number of failed drug trials.
Read at Bloomberg →
A new generation of AI companies believes it can reduce the number of failed drug trials.
<iframe src="https://statesidedaily.com/embed/cluster/fc81ded6882755bc565aa4a503d21abbbc2b89f0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Roche Uses Recursion AI to Uncover New Brain Disease Targets"></iframe>